Lv21
110 积分 2023-12-05 加入
Clarification of the efficacy of tezepelumab in the phase 2a COURSE trial
1小时前
待确认
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1小时前
已完结
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma
1小时前
已完结
皖公网安备34019202002308
